Colchicine is an antimitotic agent used to treat gout and Behçet's disease (Cerquaglia et al. 2005, Saleh & Arayssi 2014, Angelidis et al. 2018). It works by decreasing inflammation. Colchicine primarily inhibits tubulin (TUBB) (Lu et al. 2012), preventing microtubule polymerisation and thereby disrupts inflammasome activation, microtubule-based inflammatory cell chemotaxis, generation of leukotrienes and cytokines, and phagocytosis.